lifevantage glp-1 side effects drugs: Illuminating their full effect profile Support Your Wellness with LifeVantage

Check with your healthcare provider or visit trial registries to see if you qualify

On average, patients lose 15% of their body weight with GLP-1 injections along with consistent lifestyle changes

Any suspected side effects from retatrutide or other unlicensed products should be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk

Gastrointestinal events were the most common adverse events in both groups and generally occurred during dose escalation

These referral triggers align with guidance applicable to the broader GLP-1 drug class and represent prudent patient safety practice

4.3 % in the retatrutide 4/8/12 mg group and n = 2